Therapeutic Drug Monitoring of Isavuconazole: Lessons Learnt from a Real-life Setting in a Tertiary Care Center in India-Reference-Cited by-同舟云学术

Therapeutic Drug Monitoring of Isavuconazole: Lessons Learnt from a Real-life Setting in a Tertiary Care Center in India

Published:2023-03-31 Issue:4 Volume:27 Page:260-264
ISSN:0972-5229
Container-title:Indian Journal of Critical Care Medicine
language:en
Short-container-title:

Author:

Saseedharan Sanjith,Prayag Parikshit S,Soman Rajeev N,Panchakshari Shweta P,Ajapuje Preeti S,Mahale Namita P,Dhupad Surabhi,Patwardhan Sampada A,Naik Sadanand S,Narawade Sharwari,Athavale Anand,Melinkeri Sameer,Prayag Amrita P

Publisher

Jaypee Brothers Medical Publishing

Subject

Critical Care and Intensive Care Medicine

Link

https://www.ijccm.org/doi/pdf/10.5005/jp-journals-10071-24443

Reference10 articles.

1. 1. Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SC, Dannaoui E, Hochhegger B, et al. Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis 2019;19(12):e405–e421. DOI: 10.1016/S1473-3099(19)30312-3.

2. 2. Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, et al. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): A phase 3, randomised-controlled, non-inferiority trial. Lancet 2016;387(10020):760–769. DOI: 10.1016/S0140-6736(15)01159-9.

3. 3. McCarthy MW, Moriyama B, Petraitiene R, Walsh TJ, Petraitis V. Clinical pharmacokinetics and pharmacodynamics of isavuconazole. Clin Pharmacokinet 2018;57(12):1483–1491. DOI: 10.1007/s40262-018-0673-2.

4. 4. Patterson TF, Thompson III GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis 2016;63(4):e1–e60. DOI: 10.1093/cid/ciw326.

5. 5. Andes D, Kovanda L, Desai A, Kitt T, Zhao M, Walsh TJ. Isavuconazole concentration in real-world practice: Consistency with results from clinical trials. Antimicrob Agents Chemother 2018;62(7): e00585–e005818. DOI: 10.1128/AAC.00585-18.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole;Medical Mycology;2024-08-13

2. Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill?;Indian Journal of Critical Care Medicine;2023-05-31